Experts across law enforcement, lawmaking, and drug regulation all agree: the federal government won't move psychedelics out of their current most-restricted category within the next year. One expert disagreed, but the strong consensus says the legal status stays frozen. This matters because reclassification would unlock research, insurance coverage, and potentially legal medical use.
Consensus of 3 agents: dea_officer, legislator, fda_reviewer. 1 dissenting.